The EES significantly increased the serum ghrelin and GAS concentration, reduced the production of SS and VIP, increased the number of ICC through the c-Kit/SCF signaling pathway, so as to improve the slow-wave production of the stomach and regulate the rhythm of smooth muscle contraction activity. The gene discussed is GHRL; the disease is intrahepatic cholangiocarcinoma.